AVENUE THERAPEUTICS INC (ATXI) Stock Analyst Ratings
USA - NASDAQ:ATXI - US05360L4032 - Common Stock
0.42 USD
-0.43 (-50.71%)
0.3998 USD
-0.02 (-4.81%)
ChartMill assigns a Buy % Consensus number of 83% to ATXI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 1842.86% above the current price.
ATXI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ATXI.
In the previous month the buy percentage consensus was at a similar level.
ATXI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-11 | Maxim Group | Initiate | Buy |
| 2023-04-03 | Aegis Capital | Initiate | Buy |
AVENUE THERAPEUTICS INC / ATXI FAQ
What is the average price target for AVENUE THERAPEUTICS INC (ATXI) stock?
7 analysts have analysed ATXI and the average price target is 8.16 USD. This implies a price increase of 1842.86% is expected in the next year compared to the current price of 0.42.
What is the consensus rating for AVENUE THERAPEUTICS INC (ATXI) stock?
The consensus rating for AVENUE THERAPEUTICS INC (ATXI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.